J Nanobiotechnology January 2020 PMID 31918721

Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.

Gaofeng Liang, Yanliang Zhu, Doulathunnisa Jaffar Ali, Tian Tian, Huantian Xu, Ke Si, Bo Sun, Baoan Chen, Zhongdang Xiao

Mentions

6
Peak: 1 in Jan 2020
across 2 sources since Jan 2020

Extended reach

3,226
potential audience

Total likes

2

Video views

155

Mentions per month

Jan 2020 – May 2024

Where it's discussed

  • YouTube5 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The discussions express enthusiasm about the article's innovative use of exosomes, with phrases such as 'game-changing' and 'promising approach,' reflecting high interest and recognition of its potential impact; analytical comments on molecular mechanisms also show engagement and understanding of its significance.

AgreementModerate agreement

Many discussions highlight positive views on the potential of engineered exosomes in overcoming drug resistance, indicating general agreement with the study's significance.

InterestHigh interest

The high interest score reflects strong curiosity about innovative approaches to cancer treatment, as seen in comments mentioning 'exciting potential' and 'promising strategy.'

EngagementModerate engagement

Posts often discuss mechanisms like miR-21 inhibition and tumor suppression, indicating moderate engagement with specific scientific details.

ImpactModerate impact

Participants recognize the method's potential to improve therapy outcomes, but some aspects remain speculative, resulting in a moderate impact score.

Abstract in brief

  • Engineered exosomes were used to deliver both the chemotherapy drug 5FU and a miR21 inhibitor to resistant colon cancer cells, effectively overcoming drug resistance and reducing tumor growth.
  • The study found that this co-delivery system increased cellular uptake, downregulated miR21 levels, induced cell cycle arrest, promoted cell death, and restored the expression of tumor-suppressor genes, leading to significant tumor suppression in mice.
  • This approach demonstrates a promising strategy for combining genetic and chemotherapeutic treatments via exosomes to overcome drug resistance in colon cancer therapy.

Top posts

Most liked on X and Bluesky
NanoTrac Technologies
@nanotrac · X

J Nanobiotechnology Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer: 5-Fluorouracil (5-FU) has been commonly prescribed for patients with… https://t.co/nwtxgslBm9 #Research via @BioMedCentral

Jan 10, 2020 · 1 like · 3,073 followers View post →

All mentions

NanoTrac Technologies
@nanotrac · X

J Nanobiotechnology Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer: 5-Fluorouracil (5-FU) has been commonly prescribed for patients with… https://t.co/nwtxgslBm9 #Research via @BioMedCentral

Jan 10, 2020 · 1 like · 3,073 followers View post →